Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Novel Biomarkers of Primary Open-Angle Glaucoma
暂无分享,去创建一个
[1] J. Castillo,et al. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified , 2016, Leukemia & lymphoma.
[2] E. Sertoğlu,et al. Accurate Use of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration , 2014, Ocular immunology and inflammation.
[3] T. Güngör,et al. Two new inflammatory markers associated with Disease Activity Score‐28 in patients with rheumatoid arthritis: neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio , 2015, International journal of rheumatic diseases.
[4] Hilal Kahraman,et al. Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration , 2015, Ocular immunology and inflammation.
[5] A. Ejaz,et al. Neutrophil‐lymphocyte and platelet‐lymphocyte ratio in patients after resection for hepato‐pancreatico‐biliary malignancies , 2015, Journal of surgical oncology.
[6] Ying Li,et al. Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. , 2015, Journal of diabetes and its complications.
[7] A. V. Ozeç,et al. Association of Neutrophil/Lymphocyte Ratio and Retinal Vein Occlusion , 2015 .
[8] Emine Esra Karaca,et al. Neutrophil-to-Lymphocyte Ratio May Predict Progression in Patients With Keratoconus , 2014, Cornea.
[9] M. Bozbay,et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in infective endocarditis: in-hospital and long-term clinical results. , 2014, The Journal of heart valve disease.
[10] Mirjana Janićijević-Petrović,et al. Evaluation of central corneal thickness in patients with ocular hypertension and primary open-angle glaucoma. , 2014, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.
[11] S. Inan,et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. , 2013, Diabetes technology & therapeutics.
[12] E. Campos,et al. Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. , 2012, Life sciences.
[13] J. Crowston,et al. Is primary open‐angle glaucoma part of a generalized sensory neurodegeneration? A review of the evidence , 2012, Clinical & experimental ophthalmology.
[14] C. Cheung,et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes , 2012, Molecular vision.
[15] M. Wax. The case for autoimmunity in glaucoma. , 2011, Experimental eye research.
[16] K. Rezaei,et al. Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. , 2010, Investigative ophthalmology & visual science.
[17] H. Abe,et al. Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma. , 2010, Investigative ophthalmology & visual science.
[18] D. Liao,et al. Serum Cytokine Alteration is Associated With Optic Neuropathy in Human Primary Open Angle Glaucoma , 2009, Journal of glaucoma.
[19] A. Coleman,et al. The logic behind target intraocular pressure. , 2009, American journal of ophthalmology.
[20] F. Salazar-Onfray,et al. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. , 2007, Cytokine & growth factor reviews.
[21] C. Creuzot-Garcher,et al. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs , 2006, British Journal of Ophthalmology.
[22] A. Kesler,et al. C-Reactive Protein Levels in Normal Tension Glaucoma , 2005, Journal of glaucoma.
[23] N. Pfeiffer,et al. Analysis of Autoantibody Repertoires in Sera of Patients with Glaucoma , 2003, European journal of ophthalmology.
[24] E. Stefánsson,et al. The impact of ocular blood flow in glaucoma , 2002, Progress in Retinal and Eye Research.
[25] M. Wax,et al. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. , 2001, Investigative ophthalmology & visual science.
[26] M. Wax,et al. Serum autoantibody against glutathione S-transferase in patients with glaucoma. , 2001, Investigative ophthalmology & visual science.
[27] Yoko Ikeda,et al. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. , 2000, Investigative ophthalmology & visual science.
[28] M. Wax,et al. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. , 2000, Archives of ophthalmology.
[29] G Bellone,et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. , 1999, The American journal of pathology.
[30] M. Wax,et al. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. , 1999, Archives of ophthalmology.
[31] A. Pestronk,et al. Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. , 1995, Investigative ophthalmology & visual science.